Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia
Hiroya Ichikawa,
Kimikazu Yakushijin,
Yoshiharu Miyata,
Hirofumi Kanehira,
Miki Joyce,
Yuri Hirakawa,
Sakuya Matsumoto,
Shigeki Nagao,
Rina Sakai,
Keiji Kurata,
Akihito Kitao,
Yasuyuki Saito,
Shinichiro Kawamoto,
Katsuya Yamamoto,
Mitsuhiro Ito,
Tohru Murayama,
Hiroshi Matsuoka,
Hironobu Minami
Affiliations
Hiroya Ichikawa
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Kimikazu Yakushijin
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Yoshiharu Miyata
BioResource Center Kobe University Hospital Kobe Japan
Hirofumi Kanehira
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Miki Joyce
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Yuri Hirakawa
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Sakuya Matsumoto
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Shigeki Nagao
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Rina Sakai
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Keiji Kurata
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Akihito Kitao
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Yasuyuki Saito
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Shinichiro Kawamoto
Transfusion Medicine and Cell Therapy Kobe University Hospital and Graduate School of Medicine Kobe Japan
Katsuya Yamamoto
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Mitsuhiro Ito
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Tohru Murayama
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Hiroshi Matsuoka
BioResource Center Kobe University Hospital Kobe Japan
Hironobu Minami
Division of Medical Oncology/Hematology Department of Medicine Kobe University Hospital and Graduate School of Medicine Kobe Japan
Abstract Sinusoidal obstruction syndrome (SOS) is a fatal complication of hematopoietic stem cell transplantation (HSCT). Early diagnosis for SOS can improve clinical outcomes significantly. Here, we performed a retrospective study to investigate the Cairo diagnostic criteria, in which SOS was defined as the development of two or more in seven events, including transfusion‐refractory thrombocytopenia. Among 154 cases of allogeneic HSCT, 10 cases of SOS using the European Society for Blood and Marrow Transplantation criteria (EBMT16) as the reference standard were identified. The original Cairo criteria could diagnose SOS 5 days earlier than any other established criteria, with some false‐positive results (sensitivity = 100.0%; specificity = 72.2%). When the cutoff was set to three events for the Cairo criteria, the diagnosis of SOS could be made 3 days earlier than that using the EBMT16 criteria, with comparable precision (specificity = 86.1%). The accuracy of the Cairo criteria improved further when the cutoff point was set to four (specificity = 93.8%). The fulfillment of the Cairo criteria was associated with high mortality. Based on our results, the Cairo criteria were also considered clinically useful, especially at three or four cutoff points. Further studies are required to validate and refine the criteria.